04/17/2026
🧬 Mitochondrial Health
Based on Telmisartan Protects Mitochondrial Function Study
🔬 Core Finding
This study demonstrates that telmisartan (a blood pressure medication) has protective effects on mitochondrial function, particularly in a model of Parkinson’s disease.
➡️ The key takeaway:
Improving mitochondrial function may directly improve neurological health and physical function (like movement and gait).
⚡ How It Impacts Mitochondria
1. 🧪 Supports Mitochondrial Biogenesis
Increases PGC-1α, a master regulator of mitochondrial production
Promotes formation of new, healthy mitochondria
👉 Functional meaning:
Supports energy production and cellular resilience
2. 🔋 Preserves ATP (Energy Production)
Protects mitochondrial ability to produce ATP (cellular energy)
Prevents energy failure seen in neurodegenerative disease
👉 Clinical relevance:
Low ATP = fatigue, muscle weakness, brain fog
3. 🔄 Improves Mitochondrial Dynamics
Increases proteins like MFN1 (mitofusin-1)
Supports proper mitochondrial fusion and networking
👉 Functional meaning:
Healthier mitochondria = better communication and efficiency
4. 🧠 Reduces Mitochondrial-Driven Cell Death
Decreases neuronal apoptosis (cell death)
Protects dopamine-producing neurons
👉 Key insight:
Mitochondrial dysfunction is a driver of neurodegeneration, not just a byproduct
5. 🔥 Reduces Inflammation & Oxidative Stress
Lowers inflammatory markers (iNOS, microglial activation)
Reduces oxidative damage to mitochondria
👉 Functional connection:
Inflammation + oxidative stress = mitochondrial damage cycle
🔗 Key Pathway Identified
The protective effects occur through:
➤ Akt / GSK3β / PGC-1α pathway
This pathway is critical for:
Cell survival
Mitochondrial biogenesis
Energy metabolism
Neuroprotection
🧠 Big Picture for Mitochondrial Health
This study reinforces several core mitochondrial principles:
✔ Mitochondria are central to chronic disease
Especially neurological conditions
Energy failure drives symptoms
✔ Protecting mitochondria improves function
Not just structure—real clinical outcomes improved (gait, movement)
✔ Targeting signaling pathways matters
Mitochondrial health is regulated at the cellular signaling level, not just nutrients
🌿 Functional Medicine Perspective
This aligns strongly with functional and cellular medicine approaches:
Focus on mitochondrial support as a root cause strategy
While We Address:
Oxidative stress
Inflammation
Nutrient deficiencies
Genetic susceptibility
👉 While this study used a medication, similar pathways may be influenced by:
Nutrition
Targeted supplementation
Lifestyle interventions
⚠️ Important Clinical Context
This was an animal study (mouse model)
Results are promising but not directly translatable to humans yet
Telmisartan is not currently used specifically for mitochondrial disease and will need to be prescribed by your provider. If you would like to try this medication for a non-FDA approved reason such as Mitochondrial Disease I recommend printing the attached article for your provider to review. Don't expect this medication to be prescribed on the same day as your visit. Give them time to review the information and discuss their thoughts with a follow up visit. If they will not prescribe this medication to you for a Mitochondrial Disease condition then seek help from a Holistic, Functional, Integrative, or Cellular Medicine trained provider capable of writing prescriptions.
💡 Key Takeaway for Patients
Healthy mitochondria are essential for:
Energy
Brain function
Muscle performance
Disease prevention
Protecting and supporting mitochondrial function may play a major role in improving outcomes in complex and chronic diseases.
🩺 Bottom Line
This research highlights that:
➡️ Mitochondrial dysfunction is a key driver of disease
➡️ Targeting mitochondrial pathways can improve real symptoms
➡️ Future treatments may focus heavily on mitochondrial protection and regeneration
Reference Article:
These results indicate that Tel protects mitochondrial function and gait in a mouse model of PD by modulating the Akt/GSK3β/PGC1α pathway.